Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 24, 2009The Journal of Infectious DiseasesOpen Access

Associations betweenCYP2B6Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans

View Full Paper
Ask AI
Bookmark
Share

Authors

DHDavid W. HaasMeharry Medical CollegeTGTebeb GebretsadikVanderbilt University Medical CenterGMGail MayoVanderbilt University Medical Center

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Haas et al. (2009) studied this question.

synapsesocial.com/papers/6aae05ced2bf052ff295b23fhttps://doi.org/10.1086/597125
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacokinetics of nevirapine: initial single-rising-dose study in humans1993 · 102 citations
  2. 2Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study2006 · 223 citations
  3. 3Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV‐infected patients in Uganda2007 · 121 citations
  4. 4Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine2007 · 381 citations
  5. 5Pharmacogenetics of Long‐Term Responses to Antiretroviral Regimens Containing Efavirenz and/or Nelfinavir: An Adult AIDS Clinical Trials Group Study2005 · 257 citations